Anti-GBM Disease
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Anti-CD19/BCMA Universal CAR-T Cell Therapy RD06-05 in Patients With Autoimmune Diseases. (NCT07203404) | Nanjing Bioheng Biotech Co., Ltd. | 2025-07-24 |
Track Anti-GBM Disease automatically
Every clearance here is in the API, with alerts when new ones post.